Brief: DRI Healthcare Trust Comments On FDA Approval Of Vonjotm (Pacritinib)

CTI Biopharma

01/03/2022 12:14

March 1 (Reuters) - Dri Healthcare Trust  DHT_u.TO :
    * DRI HEALTHCARE TRUST COMMENTS ON FDA APPROVAL OF VONJOTM
(PACRITINIB)
    * DRI HEALTHCARE TRUST - APPROVAL TRIGGERS COMPLETION OF
TRANSACTION WITH CTI FOR A TIERED ROYALTY ON VONJO FOR US$60
MILLION

Source text for Eikon:  ID:nCNWr0MRWa 
Further company coverage:  DHT_u.TO 

 ((reuters.briefs@thomsonreuters.com;))